RegenLab France
About
RegenLab France is part of Regen Lab SA, a leader in regenerative medicine, specializing in autologous cell therapies. Founded in 2003 and based in Le Mont-sur-Lausanne, Switzerland, the company focuses on preparing Platelet-Rich Plasma (PRP) from patients' own blood to enhance healing and tissue regeneration. The company develops and manufactures a range of medical devices for regenerative therapies, including PRP therapies, combination therapies with hyaluronic acid, and advanced cell therapy products. RegenLab France operates a GMP-certified facility, ensuring high safety and quality standards. Its patented technologies allow for precise blood component separation, contributing to standardized cell therapy products. With a presence in over 160 countries, RegenLab has treated more than 2 million patients, primarily in orthopedics and regenerative medicine. The company is committed to ongoing research and development to expand its offerings and address unmet medical needs.
Technologies
Keywords
Company Information
-
Employees 51
-
Founded 2019
Location
2 Avenue de Laponie, Les Ulis, Ile-de-France, France, 91940